Faculty Leadership Team (Clinical Oncology)

The Clinical Oncology (CO) Faculty Leadership Team (FLT) has delegated responsibility from the Trustee Board.

Overall purpose

• The COFLT oversees the delivery of the strategic priorities of the RCR in the context of the CO Faculty and strategically manages the affairs of the CO Faculty.
• The COFLT is responsible for agreeing and implementing policy relating to the Faculty.
• The COFLT has oversight of the role and function of relevant sub-committees and working groups.

Responsibilities

The CO Faculty Leadership Team is responsible for:

1. Overseeing the work of the CO Faculty and any boards, sub-committees or working groups of the COFLT so as to ensure that decisions are implemented appropriately.

2. Co-ordinating the work of any sub-committees, working groups or similar bodies within the Faculty.

3. Taking decisions within the policy and aims of the CO Faculty and the RCR as authorised by the Trustee Board.

4. Ensuring the CO Faculty operates within its overall budget.

5. Taking action on matters properly referred to it by the Trustee Board.

6. Advising the Trustee Board on the conduct and discharge of the work of the CO Faculty.

7. Referring to the Trustee Board relevant matters of importance to the CO Faculty or to the RCR as a whole.

Sub-Committees

The CO Faculty Leadership Team shall:

8. Establish such boards, sub-committees and working groups as are required within the resources approved by the Board of Trustees to enable the work of the Faculty to be effectively discharged.

9. Oversee those boards, committees and working groups which have delegated responsibility direct from the COFLT, as amended from time to time.

10. Ensure that each such group has clear terms of reference that outline its role, function and delegated responsibility, and that role descriptions are in place. 

11. Consider proposals for new projects and workstreams from its boards, committees and working groups, as appropriate.

Membership

12. Membership of the COFLT comprises:

• Vice-President, Clinical Oncology
• Medical Director, Education and Training, Clinical Oncology
• Medical Director, Professional Practice, Clinical Oncology
• President
• Medical Director, Membership and Business
• Such senior staff of the College as shall from time-to-time be determined by the COFLT.

13. All COFLT members are eligible to vote.

14. The honorary Officers of the College are entitled to attend meetings of either FLT.

Chair

15. The COFLT is chaired by the Vice-President of the CO Faculty. In the absence of the Vice-President, the COFLT is chaired by a nominee from among the FLT, in practice another Officer.

16. The duties of the Chair include:

• Chairing all meetings
• Agreeing agenda and meeting papers
• Ensuring that the Terms of Reference are observed
• Engaging all members of the COFLT in the work, in accordance with the RCR’s values
• Ensuring that accurate meeting records are maintained
• Representing the COFLT at CO Faculty Board meetings at least twice a year
• Reporting to the Trustee Board on behalf of the COFLT.

Operation

17. The COFLT will usually meet nine times a year.

18. Meetings may be held by virtual means or remote attendance.

19. The COFLT will conduct its business in line with RCR values.

20. Members will abide by any stated or implied confidentiality that relates to the work of the COFLT during or after any period of membership.

21. Members will comply with the provisions of the Data Protection Act 2018 as regards processing of any personal data where it is made available to them as part of their work.

22. At meetings of the COFLT, five members including at least two Officers and one senior staff member will form a quorum.

23. For decisions taken remotely, a simple majority of members will be sufficient for decision-making. For matters that are of a clinical or medical nature, a simple majority of Officers from the Clinical Oncology Faculty will be sufficient for decision-making. The final decision on what constitutes a clinical or medical matter will rest with the Vice President.

24. Where there is not a clear majority on a decision, the Chair will have a casting vote.

25. A written record will be produced after each meeting, to be approved by the members.

Approved by Trustee Board: September 2024
Review date: September 2025